Award

R01 HL 109002

Funder: National Institutes of Health

Funded outputs count: 8

Funder award ID: R01 HL 109002

OpenAlex ID: G9000059020

8-aminoguanine as a therapeutic strategy to reverse hallmarks of urothelial cell aging

2026 · Lori A. Birder, Amanda Wolf-Johnston, et al. · Scientific Reports

Rationale for the Use of 8‐Aminoguanine for the Management of Cystitis

2026 · Lori A. Birder, Joel N. H. Stern, et al. · International Journal of Urology

Oral 8-aminoguanine against age-related retinal degeneration

2025 · Abhishek Vats, Yibo Xi, et al. · Communications Biology · 2

Purine nucleoside phosphorylase as a target for the treatment of interstitial cystitis/bladder pain syndrome with and without Hunner lesions

2024 · Lori A. Birder, Amanda Wolf-Johnston, et al. · Scientific Reports · 4

Purine nucleoside phosphorylase inhibition is an effective approach for the treatment of chemical hemorrhagic cystitis

2024 · Amanda Wolf-Johnston, Youko Ikeda, et al. · JCI Insight · 7

Hypoxanthine Induces Signs of Bladder Aging With Voiding Dysfunction and Lower Urinary Tract Remodeling

2023 · Lori A Birder, Amanda S Wolf-Johnston, et al. · The Journals of Gerontology Series A · 13

Effects of vasopressin receptor agonists on detrusor smooth muscle tone in young and aged bladders: Implications for nocturia treatment

2022 · Youko Ikeda, Irina Zabbarova, et al. · Continence · 12

Purine nucleoside phosphorylase inhibition ameliorates age-associated lower urinary tract dysfunctions

2020 · Lori A. Birder, Amanda Wolf-Johnston, et al. · JCI Insight · 37